Skip to main content
. 2019 Sep 18;6:118. doi: 10.3389/fcvm.2019.00118

Figure 3.

Figure 3

Different source/dose of UM206 studies (Studies E, F, and G): (A) Cardiac function (as measured by ejection fraction [EF%]), (B) Infarct size determination (measured by IHC and expressed as % of tissue length), and (C) Myofibroblast count (measured by IHC and expressed as % of infarct area). EF, ejection fraction; IHC, immunohistochemistry. Data are presented as mean ± SEM.